RENALIS LLC – Trademark Portfolio

Entity Type: 16

RENALIS LLC holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 4 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include CECE. The owner is based in CHICAGO, IL.

222 W MERCHANDISE MART PLAZA, #1230

CHICAGO, IL 60654

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark
Serial #88853018
Registered 2020
RENALIS
RENALIS
Abandoned 2020
CECE
CECE
Registered 2020
CECE
CECE
Registered 2018

Trademark Classifications

RENALIS LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (4 filings)

Scientific and technological services; industrial analysis and research services

44
Medical Services (2 filings)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does RENALIS LLC have?

RENALIS LLC has 4 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 abandoned.

What trademark classes does RENALIS LLC file in?

RENALIS LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 44 (Medical Services). Class 42 covers scientific and technological services; industrial analysis and research services.

What are RENALIS LLC's most well-known trademarks?

RENALIS LLC's registered trademark portfolio includes well-known marks such as CECE. These are among 3 currently registered trademarks in the portfolio.

What is RENALIS LLC's trademark registration success rate?

RENALIS LLC has a 75% trademark registration rate, with 3 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.